Warning Letter – Crystal Medical Technology – Dental Implants

Crystal Medical Technology 9/14/00 Dental Implant Devices

The inspection revealed deviations from Part 820 including failure to have a manufacturing validation study protocol and to validate software manufacturing equipment and the autoclave sterilization cycle, failure to conduct internal audits, incomplete Device Master Records and Standard Operating Procedures, no Design Plan, no change control procedures and no verification acceptance criteria.

FDA New Orleans District
SoftwareCPR Keywords: production software

Expand your access! Subscribe today!

Corporate Office

+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TN) and Italy.